期刊文献+

不同透析方式尿毒症患者血清胱抑素C清除的研究 被引量:2

Research of the Clearance of Serum Cystatin C on Different Dialysis Modalities
下载PDF
导出
摘要 目的:评价以不同方式透析的尿毒症患者血清胱抑素C清除效果。方法:将36例维持性血液透析患者随机分为A、B两组,每周透析3次,A组每周血液透析滤过(hemodiafiltration,HDF)1次,B组每两周血液透析滤过1次。每两月检查透前、透后血清胱抑素C、B2-微球蛋白浓度,观察6个月。结果:A组前、中、后二月透前血清胱抑素C浓度分别为(6.79±1.45)、(5.73±1.88)、(4.48±1.48)mg/L,B2-微球蛋白浓度分别为(22.54±2.20)、(20.06±6.20)、(18.11±6.10)mg/L。B组前、中、后二月透前血清胱抑素c浓度分别为(6.79±1.71)、(5.89±1.38)、(5.06±1.35)mg/L,B2-微球蛋白浓度分别为(21.03±4.17)、(20.00±3.69)、(18.24±4.67)mg/L。两组前、中、后二月透前血清胱抑素C、B2-微球蛋白浓度比较差异无统计学意义|P〉O.05)。后二月透前血清胱抑素C、B2-微球蛋白浓度与前二月比较差异有统计学意义(P〈O.05)。血清胱抑素C下降率(cystatin Creduction ratio,CyRR)、B2-微球蛋白下降率(B2-microglobulin reduction rati0,B2-MRR)均40%~50%,清除效果相当。结论:每周1次HDF与每2周1次HDF对血清胱抑素C、B2-微球蛋白清除效果相似,血清胱抑素C下降率可作为理想的中分子毒素清除率指标。 Objective :To evaluate the clearance of serum eystatin C on different dialysis modalities in maintenance hemodialysis patients.Methods : 36 maintenance hemodialysis patients were divided into group A and group B with random.Each group performed dialysis thrice a week.Group A performed hemodiafiltration once a week while group B once two weeks.Cystatin C and B2-microglobulin concentration at pre-dialysis and post-dialysis were measured every two months.Results :In group A cystatin C concentrations at pre-dialysis were (6.79 ± 1.45), (5,73 ± 1.88), (4.48 ± 1.48)mg/L in the first, second and the last two months respectively. B2-microglobulin concentrations at pre-dialysis were (22.54 ± 2,20), (20.06 ± 6.20), (18.11 ± 6.10)mg/L in the first, second and the last two months respectively.In group B cystatin C concentrations at pre-dialysis were (6.79± 1.71), (5.89±1.38), (5.06±1.35) mg/L in the first, second and the last two months respectively. B2-microglobulin concentrations at pre-dialysis were (21.03 ± 2.20), (20.00 ± 3.69), (18.24 ± 4.67)mg/L in the first, second and the last two months respectively.There was no significance in cystatin C and B2-microglobulin concentration at pre-dialysis in both groups.There was significant statistical difference in cystatin C and B2-microglobulin concentration at pre-dialysis between the last two months and the first two months.Cystatin C reduction ratio and B2-microglobulin reduction ratio was 40%-50%.The efficacy of dialysis was similar.Concluslon :To perform hemodiafiltration once a week is similar to perform hemodiafihration once two weeks in removing efficacy of dialysis for serum cystatin C and B2-microglobulin.Serum cystatin C reduction ratio is an ideal marker for clearance of the middle molecular weight uremic toxins.
作者 梁国玉
机构地区 民航总医院
出处 《中外医学研究》 2012年第23期1-3,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 血清胱抑素C 血液透析 血液透析滤过 Serum cystatin C Hemodialysis Hemodiafiltration
  • 相关文献

参考文献10

  • 1Vanholder R,Van Laecke S,Glorieux G.What is new in uremic toxicity[J].Pediatr Nephrol,2008,23(8):1211-1221.
  • 2Rule A D,Bergstralh E J,Slezak J M,et al.Glomerular filtration rate estimated by cystatin C among different clinical presentations[J].Kidney Int,2006,69(8):399-405.
  • 3Shlipak M G,Praught M L,Sarnak M J.Update on cystatin C:new insights into the importance of mild kidney dysfunction[J].Curr Opin Nephrol Hypertens,2006,15(8):270-275.
  • 4Knight E L,Verhave J C,Spiegelman D,et al.Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement[J].Kidney Int,2004,65(2):1416-1421.
  • 5Dharnidharka V R,Kwon C,Stevens G.Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis[J].Am J Kidney Dis,2002,40(54):221-226.
  • 6谷红霞,陈香美.血清胱抑素C的非肾脏影响因素[J].泰山医学院学报,2009,30(11):887-888. 被引量:4
  • 7Park J S,Kim G H,Kang C M,et al.Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules[J].The Korean Journal of Internal Medicine,2010,25(1):77-81.
  • 8Krishnamurthy N,Arumugasamy K,Anand U,et al.Effect of hemodialysis on circulating cystatin C levels in patients with end stage renal disease[J].Indian Journal of Clinical Biochemistry,2010,25(1):43-46.
  • 9刘华,王蕾,高锋.血清胱蛋白酶抑制剂C在血液透析患者中的临床应用[J].检验医学,2005,20(2):134-136. 被引量:2
  • 10叶智明,史伟,梁馨苓,刘双信,王文健,彭炎强.不同透析方式及透析膜对清除血清胱抑素C的效果比较[J].新医学,2006,37(6):362-363. 被引量:14

二级参考文献17

  • 1钱家麒.关注血液透析中若干问题,进一步提高血液透析治疗水平[J].中华肾脏病杂志,2005,21(2):63-64. 被引量:30
  • 2Randers E, Erlandsen EJ. Serum cystatin C as endogenous marker of the renal function-a review [J]. Clin Chem Lab Med, 1999, 37:389-395.
  • 3Woo KT, Lau YK, Lee GSI, et al. Pattern of proteinuria in IgA nephritis by SDS-PAGE: clinical significance[J]. Clin Nephrol, 1991, 36:6-11.
  • 4Tian S, Kusano E, Tabel K, et al. Cystatin C measurement and its practical use in patients with various renal disease[J]. Clin Nephrol, 1997, 48:104-108.
  • 5BICIK Z,BAHCEBASI T,KULAKSIZOGLU S,et al.The efficacy of cystatin C assay in the prediction of glomerular filtration rate.is it a more reliable marker for renal failure[J] ? Clin Chem Lab Med,2005,43 (8):855-861.
  • 6KOENIG W,TWARDELLA D,BRENNER H,et al.Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate[J].Clin Chem,2005,51 (2):321-327.
  • 7LOCSEY L,SZEGEDI J,DAN A,et al.Homocysteine and cystatin C level changes in haemodialysed patients and connection with cerebro and cardiovascular complications[J].Acta Physiol Hung,2001,88 (3):293-299.
  • 8BOSTOM AG,KRONENBERG F,RITZ E,et al.Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels[J].J Am Soc Nephrol,2002,13 (8):2140-2144.
  • 9JERNBERG T,LINDAHL B,JAMES S,et al.Cystatin C:a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome[J].Circulation,2004,110(16):2342-2348.
  • 10FELLAH H,FEKI M,HSAIRI M,et al.Hyperhomocysteinemia and end-stage renal disease:determinants and association with cardiovascular disease in Tunisian patients[J].Clin Chem Lab Med,2003,41 (9):675-680.

共引文献17

同被引文献15

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部